EGF and cholestasis: During the tumorigenesis of cholangiocarcinoma, cholestasis and chronic inflammation may induce bile duct epithelial cells to produce variable cytokines including IL-6, IL-8, TGF-β1, TNF-α, platelet-derived growth factor, and epidermal growth factor [43].